Study of serum LDH and GGT levels in carcinoma breast
DOI:
https://doi.org/10.7439/ijbar.v7i1.2850Abstract
Background: Breast cancer is the second most common cancer in women next only to cervical cancer. Multiple factors are associated with an increased risk of developing breast cancer. For the early detection of carcinoma of breast, a number of biochemical markers have been studied to evaluate the malignancy. Aim: To analyse serum Lactate Dehydrogenase, Gamma Glutamyl Transpeptidase, liver enzymes (SGOT, SGPT, and ALP) and total proteins in diagnosis of carcinoma breast patients and compared with controls. And evaluate the relationship of serum LDH, GGT levels with ALP of carcinoma breast patients of post-menopausal age group. Material and Methods: The serum biochemical markers were estimated in 60(30-premenopausal women, 30-post menopausal women) clinically and histopathological confirmed patients with carcinoma breast and 40 number of healthy age- matched individuals served as control. Lactate dehydrogenase (LDH) Serum Gamma Glutamyl Transpeptidase (GGT), were analysed and estimated. Statistics: Data was analysed with student's paired 't'-test was determined. Results: The mean serum LDH, GGT, and ALP activities in patients with carcinoma breast were significantly (p 0.0001) increased as compared to controls, and a steady increase was observed in their levels from premenopausal to post-menopausal women. Conclusion: In this study, it is to suggest that the estimation of LDH, GGT, and ALP can be used as routine screening tests in all suspected carcinoma breast patients and for general population and can detect metastasis.Downloads
References
Mehta S, Mehta A. Breast. In: Ahmed AH, Shrivastava RB, editors. ASI Textbook of Surgery.1st ed. New Delhi: Tata Mc Graw Hill Publishing Company Ltd; 2003. p. 668-99.
Ford D, Easton DF, Stratton M. et. al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet. 1998; 62:676
Couch FJ, DeShano ML, Blackwood MA. et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med. 1997; 336:1409
Truscott BM. Carcinoma of the breast. Brit J Cancer. 1947; 1:129. doi: 10.1038/bjc.1947.15.
Collaborative Group on Hormonal Factors in Breast Cancer: Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 2012; 13:1141-51.
Brinton LA, Richesson D, Leitzmann MF, Gierach GL, Schatzkin A, Mouw T, et al. Menopausal hormone therapy and breast cancer risk in the NIH-AARP. Diet and Health Study Cohort. Cancer Epidemiol Biomarkers Prev. 2008; 17:3150-60.
Kumar, Vinay; Abul Abbas (2010). Robbins and Cotran Pathologic Basis of Disease. Philadelphia: Saunders, an imprint of Elsevier inc. p. 1090. ISBN 978-1-4160-3121-5.
Slanger TE, Chang-Claude JC, Obi N, Kropp S, Berger J, Vettorazzi E, et al. Menopausal hormone therapy and risk of clinical breast cancer subtypes. Cancer Epidemiol Biomarkers Prev. 2009, 18:1188-96.
Li CI Uribe DJ Daling JR: Clinical characteristics of different histological types of breast cancer. Br J Cancer, 2005, 93:1046-52.
Das S. The breast. In: A Concised Textbook of Surgery. 5th ed. Kolkata: Dr. S. Das publishers; 2008. p. 691-738.
Serum Lactate Dehydrogenase and Lipid Profile in Breast Cancer IJPBS 2013; 3(2): 423-43.
Rosalki SB. Gamma-glutamyl transpeptidase. Adv Clin Chem. 1975; 17:53
Choudhari A, Desai P, Indumati V, Kadi S. Activities of serum Ada, GGT and alp in carcinoma breast-a case control study for diagnostic and prognostic significance. Indian J Med Sci 2013; 67:123-129.
Kaplan MM. Alkaline phosphatase. Gastroenterology. 1972; 62: 452
Mishra Sandhya. Studies of biochemical parameters in breast cancer with and without metastasis. Indian Journal of Clinical Biochemistry. January 2004; 19 (1): 71-75.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
How to Cite
